Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs.
from Top Health News -- ScienceDaily https://ift.tt/2NWMqNX
No comments:
Post a Comment